Quent Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Quent Capital's BMY Position: Q3 2026 in Review
Quent Capital increased its Bristol-Myers Squibb (BMY) stake by 9.6% in Q3 2026, buying an estimated $17.5K and bringing the position to 3,158 shares worth $196K. The position accounts for 0.01% of the portfolio, ranked #446.
Quent Capital first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $389K in Q2 2023. 1,759 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Quent Capital held 3,158 shares of Bristol-Myers Squibb worth $196K as of Q3 2026.
- Quent Capital bought 277 Bristol-Myers Squibb shares in Q3 2026, an estimated $17.5K.
- Bristol-Myers Squibb made up 0.01% of Quent Capital's portfolio in Q3 2026, its #446 holding.
- Quent Capital first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
- Quent Capital's Bristol-Myers Squibb position peaked at $389K in Q2 2023.
- 1,759 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Quent Capital's 13F filing for Q3 2026, filed 9 Nov 2026.